Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Enhanced recovery programs inform patients while decreasing pain, length of stay

Preparing patients before surgical procedures with enhanced recovery after surgery (ERAS) programs boosts patient knowledge while reducing recuperation time and decreasing necessary drug intervention, according to the results shown at two different healthcare facilities.

Sysmex Canada introduces new hematology analyzers

Sysmex Canada, providers of automated hematology and urinalysis diagnostic testing, has launched the new XN-L Series for testing in smaller analytic devices.

Pricey hospitals don’t change after negative publicity

Attempts to publicly shame hospitals which have substantially increased prices don't appear to work.

Casamba merges with HealthWyse, TherapySource

Casamba announced the company has merged with HealthWyse of Boston and TherapySource of Birmingham, Alabama.

Thumbnail

Sparta Systems launches cloud-based Stratas Quality Management

Sparta Systems, Inc., a producer of enterprise quality management software (EQMS) solutions, has launched its cloud-based Stratas Quality Management solution.

ACA insurers get bigger premium hikes than requested

In eight states, insurance regulators approved increases in health insurance premiums for Affordable Care Act exchange plans above what companies asked for, according to an analysis in USA Today.

Thumbnail

ACA exchange enrollment could decrease in 2017

The fourth year of open enrollment in the Affordable Care Act (ACA) insurance marketplaces could see a “significant slowdown” in how many people purchase coverage, according to an analysis from Standard and Poor’s.

Minnesota nurses’ strike to end after 44 days

Striking nurses at five Alliana Health hospitals in the Minneapolis-St. Paul area have approved a new contract, ending a walkout that lasted a combined 44 days between two separate strikes.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.